Skip to main content
padlock icon - secure page this page is secure

Comparison of the effects of topical administration of a fixed combination of dorzolamide–timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs

Buy Article:

$52.00 + tax (Refund Policy)

Abstract Objective 

To determine whether the combination multiple-dose dorzolamide–timolol administered topically has any greater effects on the reduction of intraocular pressure, pupil size, and heart rate in dogs with glaucoma than do either timolol or dorzolamide alone. Procedure 

Applanation tonometry, pupil size, and heart rate measurements were made at 7 a.m., 1 p.m., and 7 p.m. daily of 12 laboratory Beagles with inherited primary open-angle glaucoma during each active phase of this study. Timolol 0.5% was administered first twice daily for 4 consecutive days. Dorzolamide 2.0% was administered next three times daily for 4 consecutive days. The fixed combination of the two (timolol 0.5% and dorzolamide 2.0%) was administered twice daily for 4 consecutive days during the final week of the study. Between administration of each drug, a withdrawal period of at least 10 days was instituted. Statistical comparisons between the effects of the three drugs were performed. Results 

Intraocular pressure (IOP) was decreased with the administration of all three drugs: timolol alone, dorzolamide alone, and the combination of the two decreased IOP after 1 day of treatment 2.83 ± 0.70 mmHg, 6.47 ± 0.32 mmHg, and 6.56 ± 0.37 mmHg, respectively. After 4 days of treatment, the IOP decreased even further: timolol alone, dorzolamide alone, and the combination of the two decreased IOP 3.75 ± 0.88 mmHg, 7.50 ± 0.29 mmHg, and 8.42 ± 0.58 mmHg, respectively. Heart rate was significantly decreased with timolol (−11.9 ± 2.0 bpm) and the combination preparation (−8.6 + 2.4 bpm), but not with dorzolamide (−3.7 ± 1.8 bpm) alone. Pupil size was significantly decreased with timolol (−1.42 + 0.40 mm) and the combination preparation (−1.3 + 0.33 mm), but not with dorzolamide (0.97 ± 0.36 mm) alone. Conclusions 

The combination dorzolamide–timolol appears to be more effective at reducing intraocular pressure in glaucomatous dogs than is either timolol or dorzolamide alone.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Cosopt®; dog; dorzolamide; glaucoma; timolol

Document Type: Research Article

Publication date: July 1, 2006

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more